Showing 2581-2590 of 4063 results for "".
- Aldeyra Therapeutics to Present at MOD Live! 2022 Meetinghttps://modernod.com/news/aldeyra-therapeutics-to-present-at-mod-live-2022-meeting/2480843/Aldeyra Therapeutics announced that Kelly Mizer, Aldeyra’s Vice President, Commercial Strategy and Operations, will present at the MOD Live! 2022 meeting, which will take place in Nashville, Tennessee, May 5–7, 2022. MOD Live! 2022 is an interactive educational program
- CooperVision Seeks Proposals for 2022 Science and Technology Awardshttps://modernod.com/news/coopervision-seeks-proposals-for-2022-science-and-technology-awards/2480832/To promote continuous advancement in contact lens research and development, CooperVision is now accepting submissions for its 2022 Science and Technology Awards program. The longstanding program fosters partnerships between recipients and CooperVision scientists to explore new dimensions in visio
- SightGlass Vision Presents 24-Month Data Demonstrating Myopia Control Efficacy for Vision Spectacle Lenseshttps://modernod.com/news/sightglass-vision-presents-24-month-data-demonstrating-myopia-control-efficacy-for-vision-spectacle-lenses/2480823/Spectacles that use SightGlass Vision Diffusion Optics Technology have demonstrated efficacy in slowing the progression of myopia in children,[1] based on 24-month interim data from its pivotal c
- Opthea Presenting Clinical Data at ARVO 2022 Annual Meetinghttps://modernod.com/news/opthea-presenting-clinical-data-at-arvo-2022-annual-meeting/2480820/Opthea announced the presentation of novel clinical data at the upcoming Association for Research in Vision and Ophthalmology (ARVO) 2022 conference, taking place in Denver, Colorado from May 1-4, 2022 and virtually from May 11-12, 2022. Jason Slakter, MD, of
- Graybug to Present Preclinical Data for GB-401 in Primary Open-Angle Glaucoma at the 2022 ARVO Annual Meetinghttps://modernod.com/news/graybug-to-present-preclinical-data-for-gb-401-in-primary-open-angle-glaucoma-at-the-2022-arvo-annual-meeting/2480808/Graybug Vision announced a poster presentation of preclinical data for GB-401 in primary open-angle glaucoma (POAG) at the upcoming Association for Research in Vision and Ophthalmology (ARVO) annual meeting, to be held at the Colorado Convention Center in Denver from May 1-4, 20
- Oyster Point Pharma to Present New Analyses at ARVO 2022https://modernod.com/news/oyster-point-pharma-to-present-new-analyses-at-arvo-2022/2480807/Oyster Point Pharma announced the presentation of data analyses at the Association for Research in Vision and Ophthalmology (ARVO) 2022, being held on May 1-4. “We are pleased to be presenting new analyses of the pivotal trial data of Tyrvaya&n
- Allegro Ophthalmics Announces New Scientific Data to Be Presented During the 2022 ARVO Annual Meetinghttps://modernod.com/news/allegro-ophthalmics-announces-new-scientific-data-to-be-presented-during-the-2022-arvo-annual-meeting/2480806/Allegro Ophthalmics announced that two scientific posters involving risuteganib, the company’s lead investigational compound in retina, will be presented during the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting. ARVO 2022 will be held May 1-4, 2022 in
- Visus Therapeutics Announces New Scientific Data to Be Presented During the 2022 ARVO Annual Meetinghttps://modernod.com/news/visus-therapeutics-announces-new-scientific-data-to-be-presented-during-the-2022-arvo-annual-meeting/2480805/Visus Therapeutics announced that it will present new scientific data at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, to be held May 1-4, 2022 in Denver, Colorado. The two presentations will highlight topics on new research findings on Brimochol PF, th
- Refractive Surgery Council Reports More Than 200,000 Laser Vision Correction Procedures Performed in Q1 2022https://modernod.com/news/refractive-surgery-council-reports-more-than-200000-laser-vision-correction-procedures-performed-in-q1-2022/2480786/The Refractive Surgery Council (RSC) reported laser vision correction (LVC) procedure volume for Q1 2022 at 200,672, representing a 5.3 percent increase over the previous quarter (Q4 2021). The report combines data for LASIK, SMILE and PRK procedures performed in the U.S. as reported by the indus
- Envision University Sets Agenda for In-Person May 2022 Conferencehttps://modernod.com/news/envision-university-sets-agenda-for-in-person-may-2022-conference/2480768/Organizers of the Envision Conference through Envision University have set the agenda for Envision Conference East with outstanding sessions and opportunities for professionals in the vision rehabilitation field. The conference will be held on May 19-21, 2022, at the Ohio State University, in col
